KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells
View all
Walgreens Boots Alliance
Deerfield, United States
Eli Lilly
Indianapolis, United States · Series E
Omnicell
Mountain View, United States
Alnylam Pharmaceuticals
Cambridge, United States · Post IPO Equity
Bristol-Myers Squibb
Lawrence Township, United States
AbbVie
North Chicago, United States · Series B
SteriPack Contract Manufacturing
Lakeland, United States · Grant
Prescient Healthcare Group
Jersey City, United States · Private Equity
Viatris
Pittsburgh, United States
Nano Hearing Aids
Phoenix, United States
Karyopharm Therapeutics
Newton, United States · Post IPO Equity
Catalent
Franklin Township, United States · Venture